Armour Thyroid and NSAIDs (Ibuprofen, Naproxen): Drug Interaction Guide

Updated May 26, 2026

Image: HealthRX.com clinical image

Armour Thyroid contains both T4 and T3 hormones in a fixed ratio, obtained from desiccated porcine thyroid tissue. The medication is FDA-approved to treat hypothyroidism. Ibuprofen and naproxen are NSAIDs that work by inhibiting cyclooxygenase and are used to manage pain, fever, and inflammatory conditions; both are available without a prescription and in prescription-strength formulations. Armour Thyroid and NSAIDs belong to different drug classes and do not share a direct metabolic pathway, though they may interact indirectly via protein binding competition and potentially through effects on renal hormone clearance.

Direct answer: Armour Thyroid and NSAIDs like ibuprofen or naproxen are not considered contraindicated together and drug interaction databases generally rate the combination as minor to moderate. The plausible mechanism is that highly protein-bound NSAIDs can displace thyroid hormone from carrier proteins in blood, which could transiently shift measured free hormone levels. Short-term, occasional NSAID use is unlikely to matter for most patients; chronic daily NSAID use, older age, reduced kidney function, or concurrent anticoagulant therapy are the situations where a clinician is more likely to want follow-up thyroid labs. This is a plausibility-based caution, not a well-quantified clinical risk backed by dedicated trials in Armour Thyroid users specifically.

What is established, what is plausible, and what is not

Status	Claim	Basis
Established	Armour Thyroid supplies both T4 and T3, unlike levothyroxine monotherapy.	FDA-approved prescribing information for Armour Thyroid.
Established	NSAIDs (ibuprofen, naproxen) are highly protein-bound drugs and are known, as a class, to have some capacity to displace other highly protein-bound compounds from serum carrier proteins.	General clinical pharmacology; this is a textbook property of protein-binding displacement, not specific to thyroid hormone.
Established	The FDA label for ibuprofen carries warnings about increased bleeding risk when combined with anticoagulant or antiplatelet therapy, and about cardiovascular and renal risk with NSAID use generally.	FDA ibuprofen prescribing information.
Plausible, not well-quantified for NDT	NSAID-related protein-binding displacement could transiently raise free T4 or free T3 measurements in a patient on Armour Thyroid, especially with sustained daily dosing of a long-half-life NSAID such as naproxen.	Consistent with general pharmacology of protein-binding displacement; magnitude and clinical significance specific to desiccated thyroid have not been confirmed by a study we can point to here.
Plausible, mechanistic only	NSAID inhibition of renal prostaglandin synthesis could theoretically alter local thyroid hormone deiodination in the kidney, since the kidney contributes to peripheral T4-to-T3 conversion.	Mechanistic reasoning from renal physiology; no dedicated clinical outcome data cited here support a measurable effect.
Not established	A specific numeric magnitude of TSH or free T4 change caused by ibuprofen or naproxen in patients taking Armour Thyroid.	No verified primary study for this specific population was located for this article; treat any precise percentage or mIU/L figure you encounter elsewhere with caution until you can check the original paper.
Requires clinician/pharmacist verification	Whether an individual patient's combination of Armour Thyroid, an NSAID, and any third medication (anticoagulant, PPI, other) needs a monitoring plan, and what that plan should be.	This is a site-judgment recommendation, not a substitute for individualized medical advice.

Why protein binding is the relevant mechanism, not enzyme competition

Thyroid hormones circulate mostly bound to carrier proteins, thyroxine-binding globulin (TBG), transthyretin, and albumin, with only a small free fraction that is biologically active. Drugs that are themselves highly protein-bound can compete for the same binding sites and shift the free/bound ratio of other drugs or hormones. Naproxen is bound to plasma protein at very high levels; ibuprofen is also substantially protein-bound, though its shorter half-life (roughly 2 to 4 hours, versus roughly 12 to 17 hours for naproxen) means any displacement effect is shorter-lived.

This is a different mechanism from the cytochrome P450 drug interactions that dominate many other classes of drug-drug interactions. Armour Thyroid is not metabolized in a way that makes it a substrate for the enzymes NSAIDs inhibit, so the concern here is about measured hormone levels and, in theory, symptom fluctuation, rather than a change in how quickly the body clears either drug.

Because Armour Thyroid contains T3 as well as T4, and T3 is less tightly protein-bound with a shorter half-life than T4, any displacement effect on the T3 component would plausibly appear and resolve faster than the same effect would with T4-only therapy. This is a reasonable inference from the pharmacology of T3 versus T4, not a finding from a head-to-head study of NDT against levothyroxine during NSAID use.

How much this matters for most people

Most patients using ibuprofen or naproxen occasionally, for a headache, muscle strain, or a few days of an acute illness, are not expected to see a clinically meaningful change in thyroid status from this mechanism. The hypothalamic-pituitary-thyroid axis in patients who still have some residual thyroid function can also compensate for small shifts in free hormone by adjusting TSH output.

The situation is different for patients who are athyreotic, meaning they have no functioning thyroid tissue of their own (after thyroidectomy or radioactive iodine ablation). These patients depend entirely on their prescribed thyroid hormone dose and lack the compensatory buffering that an intact thyroid gland provides. In this group, sustained changes in free hormone binding are more likely to have a downstream clinical effect, which is a reasonable argument for closer monitoring in this specific subgroup when a chronic NSAID is added, though we did not locate a dedicated outcome study quantifying this for Armour Thyroid specifically.

Chronic daily NSAID use, for example, naproxen taken regularly for osteoarthritis over weeks to months, is the setting where a clinician is most likely to want a thyroid function recheck, both because of the longer half-life and sustained plasma levels of naproxen and because chronic NSAID use carries its own independent risks (gastrointestinal, renal, cardiovascular) that warrant monitoring regardless of the thyroid question.

Who should be more cautious about this combination

Patients over 65
Patients with reduced kidney function
Patients taking an anticoagulant or antiplatelet drug (warfarin, apixaban, aspirin) alongside Armour Thyroid and an NSAID, the FDA ibuprofen label specifically warns of increased bleeding risk with concurrent anticoagulant or antiplatelet therapy, and thyroid hormone independently affects clotting factor metabolism, so this combination deserves particular attention
Patients with a history of gastrointestinal bleeding or ulcer disease
Patients with known cardiovascular disease, given that NSAIDs carry cardiovascular warnings on their own label and that thyroid hormone excess, even mild, has been linked in the broader endocrine literature to increased risk of atrial fibrillation, the exact magnitude of that risk in this specific drug-combination context is not something we can verify here and should be discussed with a prescriber rather than assumed from a single number

None of this amounts to an absolute contraindication. It is a case for individualized judgment, particularly in patients who already carry more than one of these risk factors at once.

Practical timing: how to space the doses

Armour Thyroid should generally be taken on an empty stomach, roughly 30 to 60 minutes before food, as with other oral thyroid hormone products, consistent taking conditions help keep absorption predictable from day to day. NSAIDs are typically taken with food to reduce stomach irritation. Taking Armour Thyroid first thing in the morning and an NSAID later with a meal naturally creates a gap of two hours or more. Patients who take their thyroid dose at bedtime should aim for a similar separation from any evening NSAID dose.

This spacing is a reasonable, low-cost precaution rather than a rule with strong direct trial support specific to this drug pair. It reduces the chance that a change in stomach acidity or gastric emptying from the NSAID affects thyroid tablet dissolution at the same time it is taken.

Monitoring: what is reasonable, and what needs your prescriber's input

For a patient who is stable on Armour Thyroid and starts a chronic (daily, ongoing) NSAID, a reasonable and commonly used practice is to check thyroid function (TSH, and free T4 and free T3 given that Armour Thyroid supplies both hormones) some weeks after starting the new medication, then again later if anything looks off, before returning to a routine monitoring schedule. Typical follow-up windows discussed in endocrine practice for medication changes that could affect thyroid hormone absorption or metabolism are in the range of four to twelve weeks, but the exact timing and any dose adjustment should come from the prescriber managing the patient's thyroid treatment, not from a fixed formula applied without lab review.

Do not adjust an Armour Thyroid dose on your own based on this article. If labs are checked and look abnormal, that adjustment needs to be made by the prescriber, taking into account the whole clinical picture.

Symptoms worth reporting to a prescriber if they appear after starting or increasing NSAID use:

New palpitations, tremor, heat intolerance, or anxiety (could reflect a relative excess of available thyroid hormone)
Worsening fatigue, cold intolerance, constipation, or unexplained weight gain (could reflect reduced thyroid hormone availability or absorption)
Any signs of gastrointestinal bleeding (black stools, unusual bruising) if an anticoagulant is also being used
Reduced urine output or new swelling, which could suggest an NSAID-related effect on the kidneys

If NSAID use leads to acid-suppressing therapy

NSAIDs can cause gastritis or ulcers, and a common clinical response is to start a proton pump inhibitor (PPI) alongside the NSAID or after GI symptoms develop. PPIs reduce stomach acid, and oral thyroid hormone tablets, including Armour Thyroid, generally rely on an acidic gastric environment for optimal dissolution and absorption. If a patient starts a PPI because of NSAID-related stomach problems, this is a more concrete and better-documented reason to recheck thyroid function than the protein-binding question alone, since reduced thyroid hormone absorption from acid suppression is a recognized clinical issue with oral thyroid products in general. Ask the prescriber managing thyroid treatment to recheck labs if a PPI is started.

Lower-interaction alternatives for pain control

For patients who want to minimize any interaction with thyroid medication, a few alternatives are worth discussing with a prescriber or pharmacist:

Acetaminophen does not share the protein-binding displacement, renal prostaglandin inhibition, or gastric mucosal effects of NSAIDs, and is often considered first for mild-to-moderate pain in patients on thyroid hormone. It carries its own dose limits and liver-related precautions that a pharmacist can review.
Topical NSAIDs (such as diclofenac gel) achieve much lower systemic drug levels than oral NSAIDs for the same local effect, which in principle reduces the protein-binding concern, though they are not equally effective for all types of pain.
COX-2 selective agents (such as celecoxib) may have a different protein-binding and gastrointestinal profile than naproxen or ibuprofen, but they carry their own cardiovascular considerations and require a prescription; a decision between agents should weigh a patient's full cardiovascular and GI risk profile, not just the thyroid question.

Does this apply to other thyroid medications too?

The protein-binding displacement mechanism is not unique to Armour Thyroid. It applies to any oral thyroid hormone product, including levothyroxine (Synthroid, Tirosint, generic levothyroxine), liothyronine (Cytomel), and other NDT brands. The one structural difference with Armour Thyroid is that it supplies T3 in addition to T4; because T3 is less protein-bound and shorter-acting, any displacement effect on the T3 portion would be expected to appear and fade faster than an equivalent effect on T4, though this has not been directly measured in a comparative study we can cite here. Patients switching between thyroid hormone products while on a chronic NSAID should expect a follow-up thyroid function check after the switch, as they would with any change in thyroid hormone formulation or dose.

Evidence boundary

Established: Armour Thyroid contains both T4 and T3. NSAIDs are highly protein-bound drugs. The FDA label for ibuprofen warns of increased bleeding risk with concurrent anticoagulant or antiplatelet use, and of gastrointestinal, renal, and cardiovascular risks with NSAID use generally.

Plausible but not well-quantified for this specific combination: That NSAID protein-binding displacement produces a clinically meaningful, measurable shift in free thyroid hormone levels in patients taking Armour Thyroid, and that renal prostaglandin inhibition meaningfully alters peripheral thyroid hormone conversion in this population.

Not established from the material reviewed for this article: Any specific numeric magnitude of thyroid hormone level change caused by ibuprofen or naproxen in patients on natural desiccated thyroid specifically. Readers who encounter a precise percentage or lab-value change attributed to this interaction elsewhere should ask their pharmacist or prescriber to verify it against the primary literature before relying on it.

When to seek urgent care rather than routine follow-up: Chest pain, signs of a gastrointestinal bleed, severe abdominal pain, or symptoms of a significant allergic reaction after starting either medication warrant urgent evaluation rather than waiting for a routine lab recheck.

Frequently asked questions

Can I take Armour Thyroid with ibuprofen?

Occasional ibuprofen use alongside Armour Thyroid is generally considered low risk. Taking the thyroid dose on an empty stomach in the morning and the ibuprofen later with food creates a natural separation. If ibuprofen is used daily for more than about two weeks, ask the prescriber managing your thyroid treatment whether a follow-up TSH check is warranted.

Is it safe to combine Armour Thyroid and naproxen?

For most people, occasional naproxen use is not considered a major concern. Naproxen's longer half-life and very high protein binding mean sustained daily use has a somewhat greater theoretical potential to affect thyroid hormone protein binding than short-acting ibuprofen. Chronic daily naproxen use is a reasonable prompt to discuss a thyroid function recheck with your prescriber.

Does ibuprofen affect thyroid blood test results?

It may, in theory, through displacement of thyroid hormone from carrier proteins, which could transiently affect measured free T4 or free T3. The size of this effect specific to Armour Thyroid has not been clearly established in the literature reviewed for this article. If you take NSAIDs regularly, mention this to whoever is interpreting your thyroid labs.

How far apart should I take Armour Thyroid and NSAIDs?

A gap of at least two hours is a reasonable practice: take Armour Thyroid first thing in the morning on an empty stomach, and the NSAID later with food. If you take Armour Thyroid at bedtime, aim for a similar separation from an evening NSAID dose.

Can NSAIDs cause hypothyroid symptoms to worsen?

This is uncommon with short-term use. Chronic NSAID use that leads to gastritis or the need for an acid-suppressing medication like a proton pump inhibitor is a more concrete reason for reduced thyroid hormone absorption than the protein-binding mechanism alone. Watch for increased fatigue, weight gain, or cold sensitivity and report them to your prescriber.

Are there safer pain relievers for people on thyroid medication?

Acetaminophen does not share the NSAID mechanisms discussed here and is often a reasonable first option for mild-to-moderate pain, subject to its own dosing limits. Topical NSAIDs deliver much lower systemic drug levels than oral NSAIDs, which reduces the protein-binding concern, though they are not effective for every type of pain.

Does Armour Thyroid interact differently with NSAIDs than Synthroid does?

The underlying protein-binding mechanism is the same. Armour Thyroid also contains T3, which is less protein-bound and shorter-acting than T4, so any displacement effect on the T3 component could appear and resolve faster. Direct comparative data between NDT and levothyroxine during NSAID use were not found for this article.

Should I tell my doctor I take Armour Thyroid before starting an NSAID, especially long-term?

Yes. Any prescriber starting a patient on a daily NSAID should know the patient's full medication list, including thyroid hormone, so they can decide whether follow-up labs are appropriate.

What symptoms suggest the combination is causing a problem?

Palpitations, tremor, anxiety, heat intolerance, or insomnia could reflect relatively higher available thyroid hormone. Worsening fatigue, constipation, dry skin, or unexplained weight gain could reflect reduced thyroid hormone effect. Either pattern is worth reporting to your prescriber rather than adjusting your own dose.

Can I take Armour Thyroid with Aleve (naproxen sodium)?

Aleve is an over-the-counter brand of naproxen sodium, and the same considerations apply as with prescription naproxen: occasional use is generally considered lower risk, while daily use for more than about two weeks is a reasonable trigger to ask about a thyroid function recheck.

References

U.S. Food and Drug Administration. Armour Thyroid (thyroid tablets, USP) prescribing information (specific label revision not verifiable at time of drafting).
U.S. Food and Drug Administration. Ibuprofen prescribing information (specific label revision not verifiable at time of drafting).

A dedicated search for primary literature specific to Armour Thyroid (natural desiccated thyroid) and NSAID interactions did not return a verifiable result at the time this article was drafted. Claims about protein-binding displacement, renal deiodination, and monitoring intervals in this article reflect general pharmacology and common endocrine practice rather than a study conducted in this specific patient population, and should be verified against current primary literature and professional guidelines before being used to guide individual patient care.